Viewing Study NCT05238168


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-25 @ 3:05 PM
Study NCT ID: NCT05238168
Status: UNKNOWN
Last Update Posted: 2022-04-19
First Post: 2022-02-03
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of Digital Follow up of Preterm Infants
Sponsor: Turku University Hospital
Organization:

Study Overview

Official Title: ePIPARI - Digital Follow-up of Preterm Infants During First Two Years
Status: UNKNOWN
Status Verified Date: 2022-04
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ePIPARI
Brief Summary: The aim is to study how a digital follow up tool can identify the preterm born children and their families who need further support or clinical interventions
Detailed Description: This study runs a digital follow up parallel to clinical follow up, up to 2 years of corrected age of the child. It evaluates the ability of the digital follow up tool to identify the problems in growth and health, eating and feeding, neurodevelopment and parental wellbeing which require further support or interventions. This study includes all infants born under 34 weeks of gestation in Turku University Hospital during years 2019-2022 and those preterm children born under 32 weeks of gestation who turn to 2 years during years 2019-2021.

Parent satisfaction about the digital follow up tool is asked at each time point and anonymously once per year. The follow up age points are the expected day of birth, 1 month, 2 months, 4 months, 8 months, 12 months, 18 months and 24 months after the expected birth date.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: